Hydralazine Hydrochloride
- Product NDC
- 70518-0637
- 11-digit product format
- 705180637
- Labeler code
- 70518
- Product ID
- 70518-0637_ee500f0e-890f-98dd-e053-2995a90aa743
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Hydralazine Hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA088467
- Marketing category
- ANDA
- Marketing start
- 2017-07-25
- Marketing end
- 0000-00-00
- Substance
- HYDRALAZINE HYDROCHLORIDE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-0637-1 | 70518063701 | 30 TABLET in 1 BLISTER PACK (70518-0637-1) | 30 tablet | 2022-11-23 | 0000-00-00 | No | No | Current |